These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 29246786)

  • 1. Linkers: The key elements for the creation of efficient nanotherapeutics.
    Hassanzadeh P; Atyabi F; Dinarvand R
    J Control Release; 2018 Jan; 270():260-267. PubMed ID: 29246786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ignoring the modeling approaches: Towards the shadowy paths in nanomedicine.
    Hassanzadeh P; Atyabi F; Dinarvand R
    J Control Release; 2018 Jun; 280():58-75. PubMed ID: 29723612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the Use of Multifunctional Mesoporous Silica Nanoparticles and Related Nanomaterials as Carriers for the Cancer Treatment.
    Song C; Wang X; Wang Y; Yu H; Cui Y; Ma T
    Curr Drug Metab; 2018; 19(2):131-141. PubMed ID: 28758578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomolecular Corona Affects Controlled Release of Drug Payloads from Nanocarriers.
    Sharifi S; Caracciolo G; Mahmoudi M
    Trends Pharmacol Sci; 2020 Sep; 41(9):641-652. PubMed ID: 32713606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics.
    Marchal S; El Hor A; Millard M; Gillon V; Bezdetnaya L
    Drugs; 2015 Sep; 75(14):1601-11. PubMed ID: 26323338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
    Yu HP; Aljuffali IA; Fang JY
    Curr Pharm Des; 2017; 23(3):481-494. PubMed ID: 28292243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advances.
    Miller-Kleinhenz JM; Bozeman EN; Yang L
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(6):797-816. PubMed ID: 25966677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium phosphate nanocarriers for drug delivery to tumors: imaging, therapy and theranostics.
    Huang D; He B; Mi P
    Biomater Sci; 2019 Oct; 7(10):3942-3960. PubMed ID: 31414096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
    Zhang W; Liu M; Liu A; Zhai G
    Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
    Bar-Zeev M; Livney YD; Assaraf YG
    Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotherapeutics in oral and parenteral drug delivery: Key learnings and future outlooks as we think small.
    Tyagi P; Subramony JA
    J Control Release; 2018 Feb; 272():159-168. PubMed ID: 29355619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of highly efficient nanocarrier-mediated delivery approaches for cancer therapy.
    Jeong K; Kang CS; Kim Y; Lee YD; Kwon IC; Kim S
    Cancer Lett; 2016 Apr; 374(1):31-43. PubMed ID: 26854717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in design of translational nanocarriers.
    Sun Q; Radosz M; Shen Y
    J Control Release; 2012 Dec; 164(2):156-69. PubMed ID: 22664472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmenting drug-carrier compatibility improves tumour nanotherapy efficacy.
    Zhao Y; Fay F; Hak S; Manuel Perez-Aguilar J; Sanchez-Gaytan BL; Goode B; Duivenvoorden R; de Lange Davies C; Bjørkøy A; Weinstein H; Fayad ZA; Pérez-Medina C; Mulder WJ
    Nat Commun; 2016 Apr; 7():11221. PubMed ID: 27071376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.
    Laurent S; Saei AA; Behzadi S; Panahifar A; Mahmoudi M
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1449-70. PubMed ID: 24870351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotherapeutics: An insight into healthcare and multi-dimensional applications in medical sector of the modern world.
    Prasad M; Lambe UP; Brar B; Shah I; J M; Ranjan K; Rao R; Kumar S; Mahant S; Khurana SK; Iqbal HMN; Dhama K; Misri J; Prasad G
    Biomed Pharmacother; 2018 Jan; 97():1521-1537. PubMed ID: 29793315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in "smart" delivery systems for extended drug release in cancer therapy.
    Kalaydina RV; Bajwa K; Qorri B; Decarlo A; Szewczuk MR
    Int J Nanomedicine; 2018; 13():4727-4745. PubMed ID: 30154657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Advancement and Obstacles in Improving the Stability of Nanocarriers for Precision Drug Delivery in the Field of Nanomedicine.
    Mahajan K; Bhattacharya S
    Curr Top Med Chem; 2024; 24(8):686-721. PubMed ID: 38409730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in biocompatible nanocarriers for delivery of chemotherapeutic cargoes towards cancer therapy.
    Ang CY; Tan SY; Zhao Y
    Org Biomol Chem; 2014 Jul; 12(27):4776-806. PubMed ID: 24737243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robust, active tumor-targeting and fast bioresponsive anticancer nanotherapeutics based on natural endogenous materials.
    Sun B; Deng C; Meng F; Zhang J; Zhong Z
    Acta Biomater; 2016 Nov; 45():223-233. PubMed ID: 27576338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.